4.7 Article

Preparation and in vitro evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorption

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 215, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113276

Keywords

Paclitaxel; Small molecule prodrug; Oral administration; Transporter PEPT1

Funding

  1. Key Research and Development Program of Shandong Province [2018CXGC1411]
  2. Natural Science Foundation for Young Scholars of China [81503261]
  3. Natural Science Foundation of Shandong Province [ZR2015HM070]

Ask authors/readers for more resources

A series of novel amphiphilic paclitaxel prodrugs were designed, synthesized, and evaluated, showing improved aqueous solubility and potential for enhanced oral bioavailability mediated by the PEPT1 transporter. These prodrugs could self-assemble into nanoparticles, effectively improving paclitaxel solubility, stability, and anticancer activity. PTX-SS-Val demonstrated particularly promising results in enhancing oral bioavailability and anticancer effects.
A series of novel amphiphilic paclitaxel (PTX) small molecule prodrugs, PTX-succinic anhydride-cystamine (PTX-Cys), PTX-dithiodipropionic anhydride (PTX-SS-COOH) and PTX-succinic anhydride-cystamine-valine (PTX-SS-Val) were designed, synthesized and evaluated against cancer cell lines. Compared with paclitaxel, these prodrugs contained water-soluble groups such as amino, carboxyl and amino acid, which improved the aqueous solubility of the prodrugs. More importantly, the valine was introduced in PTX-SS-Val molecule and made the molecule conform to the structural characteristics of intestinal oligopeptide transporter PEPT1 substrate. Thus the oral bioavailability of prodrug could be improved because of the mediation of PEPT1 transporter. These small molecule paclitaxel prodrugs could self-assemble into nanoparticles in aqueous solution, which effectively improved the solubility of paclitaxel, and had certain stability in pH 6.5, pH 7.4 buffer solutions and simulated gastrointestinal fluids. Some of these prodrugs, especially for PTX-Cys and PTX-SS-Val, exhibited nearly equal or slightly better anticancer activity when compared to paclitaxel. Further studies on PTX-Cys and PTX-SS-Val showed that both had good intestinal absorption in the rat single-pass intestinal perfusion (SPIP) experiments. Oral pharmacokinetic experiments showed that PTX-SS-Val could effectively improve the oral bioavailability of PTX. (c) 2021 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available